Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$535.99
+0.30%
Mkt Cap $12.35B
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (35 analysts)
$656.00
Range $542.00 – $964.00
Implied Upside
+22.4%
Consensus $656.00 vs current $535.99